An innovative method for the selection of inhibitors of the viral spike-glycoprotein of the SARS-CoV.
J Bioinform Comput Biol
; 19(1): 2050043, 2021 02.
Article
in English
| MEDLINE | ID: covidwho-936942
ABSTRACT
This paper has developed and described a detailed method for selecting inhibitors based on modified natural peptides for the SARS-CoV BJ01 spike-glycoprotein. The selection of inhibitors is carried out by increasing the affinity of the peptide to the active center of the protein. This paper also provides a step-by-step algorithm for analyzing the affinity of protein interactions and presents an analysis of energy interactions between the active center of a protein and the wild-type peptide interacting with it, taking into account modifications of the latter. A description of the software package that implements the presented algorithm is given on the website https//binomlabs.com/covid19.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Drug Evaluation, Preclinical
/
Spike Glycoprotein, Coronavirus
Type of study:
Prognostic study
Topics:
Traditional medicine
Language:
English
Journal:
J Bioinform Comput Biol
Journal subject:
Biology
/
Medical Informatics
Year:
2021
Document Type:
Article
Affiliation country:
S0219720020500432
Similar
MEDLINE
...
LILACS
LIS